首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   16552篇
  免费   1261篇
  国内免费   196篇
耳鼻咽喉   300篇
儿科学   247篇
妇产科学   223篇
基础医学   2871篇
口腔科学   197篇
临床医学   1447篇
内科学   3083篇
皮肤病学   1074篇
神经病学   1312篇
特种医学   961篇
外科学   1834篇
综合类   52篇
现状与发展   1篇
一般理论   3篇
预防医学   676篇
眼科学   455篇
药学   1573篇
中国医学   240篇
肿瘤学   1460篇
  2024年   11篇
  2023年   129篇
  2022年   498篇
  2021年   710篇
  2020年   385篇
  2019年   500篇
  2018年   549篇
  2017年   516篇
  2016年   767篇
  2015年   1012篇
  2014年   1154篇
  2013年   1252篇
  2012年   1729篇
  2011年   1604篇
  2010年   954篇
  2009年   794篇
  2008年   1028篇
  2007年   902篇
  2006年   761篇
  2005年   699篇
  2004年   525篇
  2003年   441篇
  2002年   349篇
  2001年   111篇
  2000年   120篇
  1999年   73篇
  1998年   56篇
  1997年   38篇
  1996年   36篇
  1995年   24篇
  1994年   16篇
  1993年   15篇
  1992年   32篇
  1991年   36篇
  1990年   30篇
  1989年   31篇
  1988年   20篇
  1987年   20篇
  1986年   7篇
  1985年   13篇
  1984年   6篇
  1983年   3篇
  1981年   4篇
  1980年   3篇
  1979年   8篇
  1975年   4篇
  1974年   8篇
  1973年   11篇
  1971年   3篇
  1968年   3篇
排序方式: 共有10000条查询结果,搜索用时 11 毫秒
1.
Moderate sedatives have been increasingly used to improve patient comfort during flexible bronchoscopy (FB). However, routine use of moderate sedation during FB is controversial because its efficacy and safety are not well established.This study aims to evaluate the efficacy and safety of moderate sedation during FB.A search was made of Medline, EMBASE, and the Cochrane Library to May 2014.Randomized controlled trials (RCTs) and quasi-RCTs were included.The main analysis was designed to examine the efficacy of moderate sedation during FB in sedation than no-sedation.The willingness to repeat FB was significantly more in sedation than no-sedation (odds ratio [OR] 2.30; 95% confidence interval [CI] 1.11–4.73; P = 0.02; I2 = 22.5). The duration of FB was shorter in sedation group than no-sedation group (standardized mean difference [SMD] −0.21; 95% CI −0.38 to −0.03; P = 0.02; I2 = 78.3%). Event of hypoxia was not significantly different between sedation and no-sedation groups (OR 0.86; 95% CI 0.42–1.73; P = 0.67; I2 = 0%). The SpO2 during procedure was not different between sedation and no-sedation groups (SMD −0.14; 95% CI −0.37 to 0.08; P = 0.21; I2 = 49.9%). However, in subgroup analysis without supplemental oxygen, the SpO2 was significantly lower in sedation than no-sedation group (SMD −0.45; 95% CI −0.78 to −0.11; P = 0.01; I2 = 0.0%).According to this meta-analysis, moderate sedation in FB would be useful in patients who will require repeated bronchoscopies as well as safe in respiratory depression. To our knowledge, although the various sedative drugs are already used in the real field, this analysis was the first attempt to quantify objective results. We anticipate more definite and studies designed to elucidate standardized outcomes for moderate sedation in FB.  相似文献   
2.
Erythema induratum of Bazin (EIB) is a form of tuberculid resulting from hypersensitivity to tuberculosis antigen. EIB occurs most commonly in middle‐aged women and is not typically seen in children. Here, we present a rare case of EIB, presenting as a chronic nodular panniculitis, in a 10‐year‐old Korean boy.  相似文献   
3.

Background

Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.

Objectives

To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.

Methods

Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.

Results

Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.

Conclusions

These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study.  相似文献   
4.
5.
6.
7.
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号